Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cerebral blood flow unaltered by BIBN-4096BS in healthy subjects

Feb. 15, 2005

Controlled-release paroxetine reported safe and effective in panic disorder

Feb. 15, 2005

Novel cannabinoid CB1 receptor agonists claimed by AstraZeneca

Feb. 15, 2005

NeuroMolecular receives award to support memantine development efforts

Feb. 15, 2005

Metabotropic glutamate (mGluR5) receptor antagonists described in patent literature

Feb. 14, 2005

XP-13512 enters phase IIb study for restless legs syndrome

Feb. 14, 2005

Phase II study of Durect's postoperative pain relief depot product progresses

Feb. 14, 2005

Positive phase III results for Nuvigil

Feb. 14, 2005

Pharmacokinetic study of TRANSDUR-based sufentanil patch completes dosing

Feb. 14, 2005

Adderall XR sales suspended in Canada

Feb. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...